myTomorrows and brainstrust partner to support patients living with brain cancer Affecting 80,000 people in England, 12% of brain tumour patients survive beyond five years of diagnosis
ALS Association partners with myTomorrows to improve clinical trial accessibility The fatal motor neurone disease currently does not have a cure available to treat patients